Long-term outcomes in breast cancer patients with ten or more positive axillary nodes treated with combined-modality therapy: The importance of radiation field selection
Authors:
- Daniel J. IndelicatoDIDaniel J. Indelicato
- Nancy P. MendenhallNMNancy P. Mendenhall
- 1 March 2007
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 67 (4) , 1043-1051
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Postmastectomy radiotherapy: Patterns of recurrence and long-term disease control using electronsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Fifteen‐year prognostic discriminants for invasive breast carcinomaCancer, 2001
- Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*Journal of Clinical Oncology, 2001
- Locoregional Recurrence Patterns After Mastectomy and Doxorubicin-Based Chemotherapy: Implications for Postoperative IrradiationJournal of Clinical Oncology, 2000
- Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast CancerNew England Journal of Medicine, 1997
- Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant ChemotherapyNew England Journal of Medicine, 1997
- Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results.Journal of Clinical Oncology, 1997
- Intensive chemotherapy with autologous bone marrow transfusion as primary treatment in women with breast cancer and more than five involved axillary lymph nodesEuropean Journal of Cancer, 1994
- High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.Journal of Clinical Oncology, 1993
- Adjuvant Systemic Therapy in Women With Early-Stage Breast Cancer at High Risk for RelapseJNCI: Journal of the National Cancer Institute, 1992